Literature DB >> 30273558

Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation.

Hailey J Jansen1, Martin Mackasey1, Motahareh Moghtadaei2, Darrell D Belke1, Emmanuel E Egom2, Jari M Tuomi3, Sara A Rafferty2, Adam W Kirkby1, Robert A Rose4.   

Abstract

Atrial fibrillation (AF) is prevalent in hypertension and elevated angiotensin II (Ang II); however, the mechanisms by which Ang II leads to AF are poorly understood. Here, we investigated the basis for this in mice treated with Ang II or saline for 3 weeks. Ang II treatment increased susceptibility to AF compared to saline controls in association with increases in P wave duration and atrial effective refractory period, as well as reductions in right and left atrial conduction velocity. Patch-clamp studies demonstrate that action potential (AP) duration was prolonged in right atrial myocytes from Ang II treated mice in association with a reduction in repolarizing K+ currents. In contrast, APs in left atrial myocytes from Ang II treated mice showed reductions in upstroke velocity and overshoot, as well as greater prolongations in AP duration. Ang II reduced Na+ current (INa) in the left, but not the right atrium. This reduction in INa was reversible following inhibition of protein kinase C (PKC) and PKCα expression was increased selectively in the left atrium in Ang II treated mice. The transient outward K+ current (Ito) showed larger reductions in the left atrium in association with a shift in the voltage dependence of activation. Finally, Ang II caused fibrosis throughout the atria in association with changes in collagen expression and regulators of the extracellular matrix. This study demonstrates that hypertension and elevated Ang II cause distinct patterns of electrical and structural remodeling in the right and left atria that collectively create a substrate for AF.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Action potential; Angiotensin II; Atrial fibrillation; Fibrosis; K(+) current; Na(+) current

Mesh:

Substances:

Year:  2018        PMID: 30273558     DOI: 10.1016/j.yjmcc.2018.09.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  16 in total

1.  Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?

Authors:  Selim Aydemir; Emrah Aksakal; Faruk Aydınyılmaz; Oktay Gülcü; İbrahim Saraç; Sidar Şiyar Aydın; Remziye Doğan; Merve Lazoğlu; Kamuran Kalkan
Journal:  Egypt Heart J       Date:  2022-07-07

2.  Moricizine prevents atrial fibrillation by late sodium current inhibition in atrial myocytes.

Authors:  Tian Zou; Qingxing Chen; Chaofeng Chen; Guijian Liu; Yunlong Ling; Yang Pang; Ye Xu; Kuan Cheng; Wenqing Zhu; Ru-Xing Wang; Ling-Ling Qian; Junbo Ge
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

3.  Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.

Authors:  Iuliia Polina; Hailey J Jansen; Tiesong Li; Motahareh Moghtadaei; Loryn J Bohne; Yingjie Liu; Pooja Krishnaswamy; Emmanuel E Egom; Darrell D Belke; Sara A Rafferty; Martin Ezeani; Anne M Gillis; Robert A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-20       Impact factor: 11.205

4.  A compartmentalized mathematical model of mouse atrial myocytes.

Authors:  Tesfaye Negash Asfaw; Leonid Tyan; Alexey V Glukhov; Vladimir E Bondarenko
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-01-17       Impact factor: 4.733

5.  Caveolin-3 is required for regulation of transient outward potassium current by angiotensin II in mouse atrial myocytes.

Authors:  Leonid Tyan; Daniel Turner; Karlie R Komp; Roman Y Medvedev; Evi Lim; Alexey V Glukhov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-08       Impact factor: 4.733

6.  Atrial Electrical Remodeling in Mice With Cardiac-Specific Overexpression of Angiotensin II Type 1 Receptor.

Authors:  Julie Demers; Anh-Tuan Ton; François Huynh; Simon Thibault; Anique Ducharme; Pierre Paradis; Mona Nemer; Céline Fiset
Journal:  J Am Heart Assoc       Date:  2022-04-18       Impact factor: 6.106

Review 7.  Role of inflammation in atrial fibrillation: A comprehensive review of current knowledge.

Authors:  Nso Nso; Kaveh R Bookani; Mark Metzl; Farshid Radparvar
Journal:  J Arrhythm       Date:  2020-12-23

Review 8.  Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).

Authors:  Emmanuel Eroume A Egom
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

9.  Natriuretic peptide receptor B maintains heart rate and sinoatrial node function via cyclic GMP-mediated signalling.

Authors:  Tristan W Dorey; Martin Mackasey; Hailey J Jansen; Megan D McRae; Loryn J Bohne; Yingjie Liu; Darrell D Belke; Logan Atkinson; Robert A Rose
Journal:  Cardiovasc Res       Date:  2022-06-29       Impact factor: 13.081

10.  Thrombin Induces Angiotensin II-Mediated Senescence in Atrial Endothelial Cells: Impact on Pro-Remodeling Patterns.

Authors:  Hira Hasan; Sin-Hee Park; Cyril Auger; Eugenia Belcastro; Kensuke Matsushita; Benjamin Marchandot; Hyun-Ho Lee; Abdul Wahid Qureshi; Gilles Kauffenstein; Patrick Ohlmann; Valérie B Schini-Kerth; Laurence Jesel; Olivier Morel
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.